These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
567 related items for PubMed ID: 17060128
1. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B. Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128 [Abstract] [Full Text] [Related]
2. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, Sarrazin C. Aliment Pharmacol Ther; 2005 Jan 15; 21(2):179-85. PubMed ID: 15679768 [Abstract] [Full Text] [Related]
3. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis. Schneider A, Caspary WF, Saich R, Dietrich CF, Sarrazin C, Kuker W, Braden B. J Clin Gastroenterol; 2007 Jan 15; 41(1):33-7. PubMed ID: 17198062 [Abstract] [Full Text] [Related]
4. Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Klatt S, Taut C, Mayer D, Adler G, Beckh K. Z Gastroenterol; 1997 Aug 15; 35(8):609-14. PubMed ID: 9297776 [Abstract] [Full Text] [Related]
5. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B. Dig Liver Dis; 2008 Sep 15; 40(9):743-8. PubMed ID: 18339592 [Abstract] [Full Text] [Related]
6. 13C-methacetin breath test correlates with clinical indices of liver disease severity in patients with primary biliary cirrhosis. Kochel-Jankowska A, Hartleb M, Jonderko K, Kaminska M, Kasicka-Jonderko A. J Physiol Pharmacol; 2013 Feb 15; 64(1):27-33. PubMed ID: 23568968 [Abstract] [Full Text] [Related]
7. [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis]. Pfaffenbach B, Götze O, Szymanski C, Hagemann D, Adamek RJ. Dtsch Med Wochenschr; 1998 Dec 04; 123(49):1467-71. PubMed ID: 9861887 [Abstract] [Full Text] [Related]
8. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats. Shirin H, Aeed H, Shalev T, Sorin V, Stavinski S, Shahmurov M, Ilan Y, Avni Y. J Gastroenterol Hepatol; 2008 Nov 04; 23(11):1762-8. PubMed ID: 19120861 [Abstract] [Full Text] [Related]
9. Continuous 13C-methacetin breath test differentiates biliary atresia from other causes of neonatal cholestasis. Shteyer E, Lalazar G, Hemed N, Pappo O, Granot E, Yerushalmi B, Gross E. J Pediatr Gastroenterol Nutr; 2013 Jan 04; 56(1):60-5. PubMed ID: 22695040 [Abstract] [Full Text] [Related]
10. [13C-methacetin breath test in chronic hepatitis C liver disease]. Oliveira AC, Reber M, Lanzoni V, Ferraz ML, Parise ER. Arq Gastroenterol; 2006 Jan 04; 43(1):41-4. PubMed ID: 16699617 [Abstract] [Full Text] [Related]
11. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans. Mion F, Queneau PE, Rousseau M, Brazier JL, Paliard P, Minaire Y. Hepatogastroenterology; 1995 Jan 04; 42(6):931-8. PubMed ID: 8847048 [Abstract] [Full Text] [Related]
12. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Adamek RJ, Goetze O, Boedeker C, Pfaffenbach B, Luypaerts A, Geypens B. Z Gastroenterol; 1999 Dec 04; 37(12):1139-43. PubMed ID: 10666836 [Abstract] [Full Text] [Related]
13. Measurement of liver function for patients with cirrhosis by 13C-methacetin breath test compared with Child-Pugh score and routine liver function tests. Liu YX, Huang LY, Wu CR, Cui J. Chin Med J (Engl); 2006 Sep 20; 119(18):1563-6. PubMed ID: 16996011 [No Abstract] [Full Text] [Related]
14. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry. Goetze O, Selzner N, Fruehauf H, Fried M, Gerlach T, Mullhaupt B. Aliment Pharmacol Ther; 2007 Jul 15; 26(2):305-11. PubMed ID: 17593076 [Abstract] [Full Text] [Related]
15. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P. J Surg Res; 2009 Dec 15; 157(2):199-207. PubMed ID: 19540521 [Abstract] [Full Text] [Related]
16. Usefulness of 13C-methacetin breath test in liver function testing in Amanita phalloides poisoning; breast feeding woman case. Hydzik P, Bielañski W, Ponka M, Wójcicki M, Lubikowski J, Pach J, Pawlik W. Clin Toxicol (Phila); 2008 Dec 15; 46(10):1077-82. PubMed ID: 18821093 [Abstract] [Full Text] [Related]
17. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis. Fasoli A, Giannini E, Botta F, Romagnoli P, Risso D, Celle G, Testa R. Hepatogastroenterology; 2000 Dec 15; 47(31):234-8. PubMed ID: 10690614 [Abstract] [Full Text] [Related]
18. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis. Koeda N, Iwai M, Kato A, Suzuki K. Aliment Pharmacol Ther; 2005 Apr 01; 21(7):851-9. PubMed ID: 15801920 [Abstract] [Full Text] [Related]
19. [The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test]. Li HX, Wang JP, Yang Y, Zhang J, Feng QL. Zhonghua Nei Ke Za Zhi; 2009 May 01; 48(5):383-7. PubMed ID: 19615155 [Abstract] [Full Text] [Related]
20. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Petrolati A, Festi D, De Berardinis G, Colaiocco-Ferrante L, Di Paolo D, Tisone G, Angelico M. Aliment Pharmacol Ther; 2003 Oct 15; 18(8):785-90. PubMed ID: 14535871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]